Related Experiment Videos
Blood lead levels among children--Rhode Island, 1993-1995
Insights
Rhode Island mandated blood lead level screening for children under 6 in 1993. This analysis of 56,379 children provides crucial data on childhood lead poisoning prevalence in the state.
Area of Science:
- Pediatric Environmental Health
- Public Health Surveillance
- Toxicology
Background:
- Mandatory screening for elevated blood lead levels (BLLs) in children under 6 began in Rhode Island in January 1993.
- Erythrocyte protoporphyrin screening was replaced by direct blood lead testing in February 1993.
Purpose of the Study:
- To characterize the burden of childhood lead poisoning in Rhode Island.
- To analyze data from the state's lead surveillance system.
Main Methods:
- Analysis of blood lead test results reported to the Rhode Island lead surveillance system.
- Data collected from March 1993 through February 1995.
- Inclusion of 56,379 children aged under 6 years.
Main Results:
- Summarizes blood lead test results for a significant cohort of young children in Rhode Island.
- Provides data on lead poisoning prevalence following mandatory screening implementation.
Conclusions:
- The study characterizes the prevalence of childhood lead poisoning in Rhode Island.
- Data informs public health strategies for lead poisoning prevention and management.
Abstract:
Since January 1993, screening of children aged < 6 years for elevated blood lead levels (BLLs) has been mandatory in Rhode Island. Erythrocyte protoporphyrin was eliminated as a method of lead screening in February 1993; since then, all children in the state have been screened for lead poisoning by testing capillary or venous blood samples for lead. From March 1993 through February 1995, results of blood lead tests of 56,379 children aged < 6 years were reported to Rhode Island's lead surveillance system. This report summarizes an analysis of these data by the Rhode Island Department of Health (RIDH) to better characterize the burden of childhood lead poisoning in the state.